NCT07544862Recruiting
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
A Prospective Study of Stapokibart Injection in Patients With Moderate-to-Severe Atopic Dermatitis (AD)
Source: ClinicalTrials.gov · Last updated 10 Jun 2026
Brief summary (registry, in English)
This study is an open label, prospective study to evaluate the safety and efficacy of Stapokibart Injection in patients with AD.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 16 Apr 2026
- Start date
- 2 Jun 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Chengdu Kangnuoxing Biopharma,Inc.
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07544862
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 2 Jun 2026 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known history of allergic reaction to Stapokibart Injection.
- Trial participants with hematologic malignancies.
- Any condition that, in the opinion of the investigator, may interfere with trial participants' ability to participate in the study.
Other
- Trial participants currently or plan participating in any interventional clinical trial.
- Women with pregnant.
Who the study is looking for
- Trial participants aged 18 years or older at baseline, with no restrictions on gender.
- Physician decision to treat trial participants with Stapokibart Injection for AD (according to the China-specific prescribing information) made prior to and independently of the participant's participation in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.